Beth Burgwyn Fuchs - Search Results

Year	Number of Results
2006	1
2007	4
2008	1
2009	1
2010	3
2011	2
2012	4
2013	2
2014	6
2015	9
2016	5
2017	7
2018	14
2019	4
2020	8
2021	5
2023	2
2024	0

1

Anti-MRSA agent discovery using Caenorhabditis elegans-based high-throughput screening.

Kim SM, Escorbar I, Lee K, Fuchs BB, Mylonakis E, Kim W. Kim SM, et al. Among authors: fuchs bb. J Microbiol. 2020 Jun;58(6):431-444. doi: 10.1007/s12275-020-0163-8. Epub 2020 May 27. J Microbiol. 2020. PMID: 32462486 Review.

2

Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Arvanitis M, Anagnostou T, Fuchs BB, Caliendo AM, Mylonakis E. Arvanitis M, et al. Among authors: fuchs bb. Clin Microbiol Rev. 2014 Jul;27(3):490-526. doi: 10.1128/CMR.00091-13. Clin Microbiol Rev. 2014. PMID: 24982319 Free PMC article. Review.

3

Vulnerability of long-term care facility residents to Clostridium difficile infection due to microbiome disruptions.

Fuchs BB, Tharmalingam N, Mylonakis E. Fuchs BB, et al. Future Microbiol. 2018 Oct;13:1537-1547. doi: 10.2217/fmb-2018-0157. Epub 2018 Oct 12. Future Microbiol. 2018. PMID: 30311778 Review.

4

Caenorhabditis elegans-based model systems for antifungal drug discovery.

Anastassopoulou CG, Fuchs BB, Mylonakis E. Anastassopoulou CG, et al. Among authors: fuchs bb. Curr Pharm Des. 2011;17(13):1225-33. doi: 10.2174/138161211795703753. Curr Pharm Des. 2011. PMID: 21470110 Free PMC article. Review.

5

Antibacterial properties of 3-(phenylsulfonyl)-2-pyrazinecarbonitrile.

Rajamuthiah R, Jayamani E, Majed H, Conery AL, Kim W, Kwon B, Fuchs BB, Kelso MJ, Ausubel FM, Mylonakis E. Rajamuthiah R, et al. Among authors: fuchs bb. Bioorg Med Chem Lett. 2015 Nov 15;25(22):5203-7. doi: 10.1016/j.bmcl.2015.09.066. Epub 2015 Sep 30. Bioorg Med Chem Lett. 2015. PMID: 26459212 Free PMC article.

6

Current and promising pharmacotherapeutic options for candidiasis.

Scorzoni L, Fuchs BB, Junqueira JC, Mylonakis E. Scorzoni L, et al. Among authors: fuchs bb. Expert Opin Pharmacother. 2021 May;22(7):867-887. doi: 10.1080/14656566.2021.1873951. Epub 2021 Feb 4. Expert Opin Pharmacother. 2021. PMID: 33538201 Free PMC article.

7

Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections.

Kourkoumpetis TK, Fuchs BB, Coleman JJ, Desalermos A, Mylonakis E. Kourkoumpetis TK, et al. Among authors: fuchs bb. Clin Infect Dis. 2012 May;54(9):1322-31. doi: 10.1093/cid/cis132. Epub 2012 Feb 23. Clin Infect Dis. 2012. PMID: 22362884 Free PMC article. Review.

8

Using non-mammalian hosts to study fungal virulence and host defense.

Fuchs BB, Mylonakis E. Fuchs BB, et al. Curr Opin Microbiol. 2006 Aug;9(4):346-51. doi: 10.1016/j.mib.2006.06.004. Epub 2006 Jun 30. Curr Opin Microbiol. 2006. PMID: 16814595 Review.

9

Auranofin coated catheters inhibit bacterial and fungal biofilms in a murine subcutaneous model.

Felix L, Whitely C, Tharmalingam N, Mishra B, Vera-Gonzalez N, Mylonakis E, Shukla A, Fuchs BB. Felix L, et al. Among authors: fuchs bb. Front Cell Infect Microbiol. 2023 May 29;13:1135942. doi: 10.3389/fcimb.2023.1135942. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37313344 Free PMC article.

10

Our paths might cross: the role of the fungal cell wall integrity pathway in stress response and cross talk with other stress response pathways.

Fuchs BB, Mylonakis E. Fuchs BB, et al. Eukaryot Cell. 2009 Nov;8(11):1616-25. doi: 10.1128/EC.00193-09. Epub 2009 Aug 28. Eukaryot Cell. 2009. PMID: 19717745 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

73 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year